Heiner Dreismann

Heiner Dreismann, former CEO of Roche Molecular Systems, has joined the executive advisory board of MyDx, maker of a multi-use handheld chemical analyzer designed for cannabis professionals and retail consumers. Under Dreismann's leadership, Roche expanded its portfolio of molecular tests and instruments. Prior to his appointment as CEO of Roche Molecular, Dreismann held other senior positions within Roche, including as head of global business development for Roche Diagnostics, European business unit manager for PCR, head of its business unit for microbiology, R&D positions in microbiology and infectious diseases, and head of manufacturing for infectious disease diagnostics.